ReviewPatient preference and adherence2018

Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia.

Constantine E Kosmas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.